Joseph M. Santomauro, Dpm, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 704 E Main St, Suite C, Moorestown, NJ 08057 Phone: 856-242-3957 Fax: 856-206-9271 |
Dr. Kathryn Elizabeth Stoedter, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 E Main St, Moorestown, NJ 08057 Phone: 856-234-5180 |
Dr. Louie Lu Shou, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 300 W Route 38 Ste A, Moorestown, NJ 08057 Phone: 609-267-9400 |
Foot Specialists Of Moorestown, Pc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 400 N Church St Ste 125, Moorestown, NJ 08057 Phone: 856-866-8998 Fax: 856-866-9746 |
Cafengiu Podiatry & Sports Medicine, Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 126 Bortons Landing Rd, Moorestown, NJ 08057 Phone: 856-810-8833 Fax: 856-810-7811 |
Joseph M. Santomauro Jr., D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 400 N Church St Ste 125, Moorestown, NJ 08057 Phone: 856-866-8998 Fax: 856-866-9746 |
Dr. Ana Maria Cafengiu, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 126 Bortons Landing Rd, Moorestown, NJ 08057 Phone: 856-810-8833 Fax: 856-810-7811 |
News Archive
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Tolterodine Tartrate Extended-release Capsules, 2 mg and 4 mg. Tolterodine Tartrate ER Capsules are the generic version of Pfizer's Detrol LA, and are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.
Stereotactic radiosurgery (SRS) offers a less invasive way to eliminate tremors caused by Parkinson's disease and essential tremor than deep brain stimulation (DBS) and radiofrequency (RF) treatments, and is as effective, according to a long-term study presented November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
The vaccine Tetravalent is manufactured by drug company Sanofi who say it will be ready to be submitted for approval by the year 2012.
US researchers report the development of a prediction tool that could help determine neurologic prognosis after in-hospital cardiac arrest.
Following a highly competitive evaluation process, National Patient Services (NPS) - A Triplefin Company has been awarded two multi-year contracts to provide Alternative Sampling and Marketing programs for two Fortune 50 Pharmaceutical Manufacturing companies.
› Verified 9 days ago